{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T21:45:31Z","timestamp":1767649531513,"version":"build-2065373602"},"reference-count":59,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T00:00:00Z","timestamp":1612310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100019174","name":"Australian Companion Animal Health Foundation","doi-asserted-by":"publisher","award":["006\/2013, 004\/2015"],"award-info":[{"award-number":["006\/2013, 004\/2015"]}],"id":[{"id":"10.13039\/501100019174","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>A field study undertaken in Australia compared the antibody responses induced in client-owned cats that had been vaccinated using two inactivated whole feline leukaemia virus (FeLV) vaccines, the monovalent vaccine Fel-O-Vax\u00ae Lv-K and the polyvalent vaccine Fel-O-Vax\u00ae 5. Serum samples from 428 FeLV-uninfected cats (118 FeLV-vaccinated and 310 FeLV-unvaccinated) were tested for anti-FeLV neutralising antibodies (NAb) using a live virus neutralisation assay to identify 378 FeLV-unexposed (NAb-negative) and 50 FeLV-exposed (NAb-positive; abortive infections) cats, following by anti-surface unit (SU) FeLV-A and FeLV-B antibody ELISA testing. An additional 42 FeLV-infected cats (28 presumptively regressively infected, 14 presumptively progressively infected) were also tested for anti-SU antibodies. NAb-positive cats displayed significantly higher anti-SU antibody ELISA responses compared to NAb-negative cats (p &lt; 0.001). FeLV-unexposed cats (NAb-negative) that had been vaccinated less than 18 months after a previous FeLV vaccination using the monovalent vaccine (Fel-O-Vax\u00ae Lv-K) displayed higher anti-SU antibody ELISA responses than a comparable group vaccinated with the polyvalent vaccine (Fel-O-Vax\u00ae 5) (p &lt; 0.001 for both anti-FeLV-A and FeLV-B SU antibody responses). This difference in anti-SU antibody responses between cats vaccinated with the monovalent or polyvalent vaccine, however, was not observed in cats that had been naturally exposed to FeLV (NAb-positive) (p = 0.33). It was postulated that vaccination with Fel-O-Vax\u00ae 5 primed the humoral response prior to FeLV exposure, such that antibody production increased when the animal was challenged, while vaccination with Fel-O-Vax\u00ae Lv-K induced an immediate preparatory antibody response that did not quantitatively increase after FeLV exposure. These results raise questions about the comparable vaccine efficacy of the different FeLV vaccine formulations and correlates of protection.<\/jats:p>","DOI":"10.3390\/v13020240","type":"journal-article","created":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T20:31:51Z","timestamp":1612384311000},"page":"240","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Anti-SU Antibody Responses in Client-Owned Cats Following Vaccination against Feline Leukaemia Virus with Two Inactivated Whole-Virus Vaccines (Fel-O-Vax\u00ae Lv-K and Fel-O-Vax\u00ae 5)"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7400-1960","authenticated-orcid":false,"given":"Mark","family":"Westman","sequence":"first","affiliation":[{"name":"Sydney School of Veterinary Science, The University of Sydney, Camperdown, NSW 2006, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0003-6930","authenticated-orcid":false,"given":"Jacqueline","family":"Norris","sequence":"additional","affiliation":[{"name":"Sydney School of Veterinary Science, The University of Sydney, Camperdown, NSW 2006, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6025-194X","authenticated-orcid":false,"given":"Richard","family":"Malik","sequence":"additional","affiliation":[{"name":"Centre for Veterinary Education, The University of Sydney, Camperdown, NSW 2006, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9750-4296","authenticated-orcid":false,"given":"Regina","family":"Hofmann-Lehmann","sequence":"additional","affiliation":[{"name":"Clinical Laboratory, Department of Clinical Diagnostics and Services, and Center for Clinical Studies, Vetsuisse Faculty, The University of Zurich, CH-8057 Z\u00fcrich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4658-6698","authenticated-orcid":false,"given":"Yasmin A.","family":"Parr","sequence":"additional","affiliation":[{"name":"MRC\u2014University of Glasgow Centre for Virus Research, Garscube Campus, Bearsden Road, Glasgow G61 1QH, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6757-3389","authenticated-orcid":false,"given":"Emma","family":"Armstrong","sequence":"additional","affiliation":[{"name":"MRC\u2014University of Glasgow Centre for Virus Research, Garscube Campus, Bearsden Road, Glasgow G61 1QH, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6636-4283","authenticated-orcid":false,"given":"Mike","family":"McDonald","sequence":"additional","affiliation":[{"name":"Veterinary Diagnostic Services, The University of Glasgow, Glasgow G61 1QH, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelyn","family":"Hall","sequence":"additional","affiliation":[{"name":"Sydney School of Veterinary Science, The University of Sydney, Camperdown, NSW 2006, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5234-1606","authenticated-orcid":false,"given":"Paul","family":"Sheehy","sequence":"additional","affiliation":[{"name":"Sydney School of Veterinary Science, The University of Sydney, Camperdown, NSW 2006, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4313-5023","authenticated-orcid":false,"given":"Margaret J.","family":"Hosie","sequence":"additional","affiliation":[{"name":"MRC\u2014University of Glasgow Centre for Virus Research, Garscube Campus, Bearsden Road, Glasgow G61 1QH, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,2,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/202567a0","article-title":"Leukaemia in the cat: A virus-like particle associated with leukaemia (lymphosarcoma)","volume":"202","author":"Jarrett","year":"1964","journal-title":"Nature"},{"key":"ref_2","first-page":"623","article-title":"Feline immunodeficiency virus and feline leukemia virus infections and their relationships to lymphoid malignancies in cats: A retrospective study (1968\u20131988)","volume":"3","author":"Shelton","year":"1990","journal-title":"J. Acquir. Immune. Defic. Syndr."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jcpa.2018.10.171","article-title":"Feline lymphoma and a high correlation with feline leukaemia virus infection in Brazil","volume":"166","author":"Cristo","year":"2019","journal-title":"J. Comp. Pathol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1751-0813.2001.tb13017.x","article-title":"Feline leukaemia virus status of Australian cats with lymphosarcoma","volume":"79","author":"Gabor","year":"2001","journal-title":"Aust. Vet. J."},{"key":"ref_5","first-page":"269","article-title":"Feline leukemia virus detection by immunohistochemistry and polymerase chain reaction in formalin-fixed, paraffin-embedded tumor tissue from cats with lymphosarcoma","volume":"57","author":"Jackson","year":"1993","journal-title":"Can. J. Vet. Res."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"McLuckie, A.J., Barrs, V.R., Lindsay, S., Aghazadeh, M., Sangster, C., and Beatty, J.A. (2018). Molecular diagnosis of Felis catus Gammaherpesvirus 1 (FcaGHV1) infection in cats of known retrovirus status with and without lymphoma. Viruses, 10.","DOI":"10.3390\/v10030128"},{"key":"ref_7","unstructured":"MacLachlan, N., and Dubovi, E. (2017). Fenner\u2019s Veterinary Virology, Retroviridae; Elsevier. [5th ed.]."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1098-612X(02)00132-8","article-title":"Feline leukaemia virus and vaccination","volume":"5","author":"Sparkes","year":"2003","journal-title":"J. Feline Med. Surg."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1128\/CVI.00034-15","article-title":"Comparative efficacy of feline leukemia virus (FeLV) inactivated whole-virus vaccine and canarypox virus-vectored vaccine during virulent FeLV challenge and immunosuppression","volume":"22","author":"Patel","year":"2015","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_10","first-page":"2","article-title":"Protection against feline leukemia virus challenge for at least 2 years after vaccination with an inactivated feline leukemia virus vaccine","volume":"11","author":"Jirjis","year":"2010","journal-title":"Vet. Ther."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.vetimm.2009.10.017","article-title":"Feline leukemia virus immunity induced by whole inactivated virus vaccination","volume":"134","author":"Torres","year":"2010","journal-title":"Vet. Immunol. Immunopathol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"5531","DOI":"10.1016\/j.vaccine.2006.12.022","article-title":"Vaccination against the feline leukaemia virus: Outcome and response categories and long-term follow-up","volume":"25","author":"Cattori","year":"2007","journal-title":"Vaccine"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/QAD.0b013e328013d88a","article-title":"Feline immunodeficiency virus pathogenesis and development of a dual-subtype feline-immunodeficiency-virus vaccine","volume":"21","author":"Yamamoto","year":"2007","journal-title":"AIDS"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"4752","DOI":"10.1016\/j.vaccine.2016.06.060","article-title":"The protective rate of the feline immunodeficiency virus vaccine: An Australian field study","volume":"34","author":"Westman","year":"2016","journal-title":"Vaccine"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0165-2427(00)00265-8","article-title":"The induction of a protective immunity against Jembrana disease in cattle by vaccination with inactivated tissue-derived virus antigens","volume":"78","author":"Hartaningsih","year":"2001","journal-title":"Vet. Immunol. Immunopathol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.virol.2009.02.008","article-title":"Vaccination reduces the viral load and the risk of transmission of Jembrana disease virus in Bali cattle","volume":"386","author":"Ditcham","year":"2009","journal-title":"Virology"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Sahay, B., and Yamamoto, J.K. (2018). Lessons learned in developing a commercial FIV vaccine: The immunity required for an effective HIV-1 vaccine. Viruses, 10.","DOI":"10.3390\/v10050277"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2174\/157016210790416361","article-title":"Feline immunodeficiency virus model for designing HIV\/AIDS vaccines","volume":"8","author":"Yamamoto","year":"2010","journal-title":"Curr. HIV Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.tvjl.2012.07.004","article-title":"Feline leukaemia virus: Half a century since its discovery","volume":"195","author":"Willett","year":"2013","journal-title":"Vet. J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.3390\/v4112684","article-title":"Clinical aspects of feline retroviruses: A review","volume":"4","author":"Hartmann","year":"2012","journal-title":"Viruses"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Westman, M., Norris, J., Malik, R., Hofmann-Lehmann, R., Harvey, A., McLuckie, A., Perkins, M., Schofield, D., Marcus, A., and McDonald, M. (2019). The diagnosis of feline leukaemia virus (FeLV) infection in owned and group-housed rescue cats in Australia. Viruses, 11.","DOI":"10.20944\/preprints201904.0278.v1"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.cvsm.2020.05.006","article-title":"What\u2019s new in feline leukemia virus infection","volume":"50","author":"Hartmann","year":"2020","journal-title":"Vet. Clin. Small Anim."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1128\/jvi.76.5.2306-2315.2002","article-title":"Longitudinal analysis of feline leukemia virus-specific cytotoxic T lymphocytes: Correlation with recovery from infection","volume":"76","author":"Flynn","year":"2002","journal-title":"J. Virol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1046\/j.1365-2567.2000.00089.x","article-title":"Feline leukaemia virus: Protective immunity is mediated by virus-specific cytotoxic T lymphocytes","volume":"101","author":"Flynn","year":"2000","journal-title":"Immunology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.2460\/javma.1991.199.10.1287","article-title":"Feline leukemia virus infection and diseases","volume":"199","author":"Hoover","year":"1991","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1128\/iai.16.1.54-59.1977","article-title":"Passive immunity to feline leukemia: Evaluation of immunity from dams naturally infected and experimentally vaccinated","volume":"16","author":"Hoover","year":"1977","journal-title":"Infect. Immun."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.virol.2004.10.050","article-title":"Re-examination of feline leukemia virus: Host relationships using real-time PCR","volume":"332","author":"Torres","year":"2005","journal-title":"Virology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.vaccine.2005.09.010","article-title":"Reassessment of feline leukaemia virus (FeLV) vaccines with novel sensitive molecular assays","volume":"24","author":"Tandon","year":"2006","journal-title":"Vaccine"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/vr.138.1.7","article-title":"Comparative studies of the efficacy of a recombinant feline leukaemia virus vaccine","volume":"138","author":"Jarrett","year":"1996","journal-title":"Vet. Rec."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1089\/aid.1996.12.379","article-title":"Efficacy of an inactivated feline leukemia virus vaccine","volume":"12","author":"Hoover","year":"1996","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0165-2427(94)07012-V","article-title":"Recombinant FeLV vaccine: Long-term protection and effect on course and outcome of FIV infection","volume":"46","author":"Holznagel","year":"1995","journal-title":"Vet. Immunol. Immunopathol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jfms.2009.05.005","article-title":"Feline leukaemia: ABCD guidelines on prevention and management","volume":"11","author":"Lutz","year":"2009","journal-title":"J. Feline Med. Surg."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1177\/1098612X13500429","article-title":"2013 AAFP feline vaccination advisory panel report","volume":"15","author":"Scherk","year":"2013","journal-title":"J. Feline Med. Surg."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1016\/S0264-410X(02)00237-2","article-title":"Protection against oronasal challenge with virulent feline leukaemia virus lasts for at least 12 months following a primary course of immunisation with Leukocell (TM) 2 vaccine","volume":"20","author":"Harbour","year":"2002","journal-title":"Vaccine"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.cimid.2016.11.014","article-title":"Comparison of three feline leukaemia virus (FeLV) point-of-care antigen test kits using blood and saliva","volume":"50","author":"Westman","year":"2017","journal-title":"Comp. Immun. Microbiol. Infect. Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jviromet.2005.06.017","article-title":"Quantitation of feline leukaemia virus viral and proviral loads by TaqMan (R) real-time polymerase chain reaction","volume":"130","author":"Tandon","year":"2005","journal-title":"J. Virol. Methods"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1128\/JCM.02584-13","article-title":"Detection of antibodies to the feline leukemia virus (FeLV) transmembrane protein p15E: An alternative approach for serological FeLV detection based on antibodies to p15E","volume":"52","author":"Boenzli","year":"2014","journal-title":"J. Clin. Microbiol."},{"key":"ref_38","unstructured":"Parr, Y.A., Beall, M.J., Leutenegger, C., Levy, J.K., Willett, B.J., and Hosie, M.J. (2016). Investigating the Biology Underlying Discordancy in FeLV Diagnostics, International Society for Companion Animal Infectious Diseases."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cimid.2015.07.004","article-title":"Determining the feline immunodeficiency virus (FIV) status of FIV-vaccinated cats using point-of-care antibody kits","volume":"42","author":"Westman","year":"2015","journal-title":"Comp. Immun. Microbiol. Infect. Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.cvsm.2006.11.011","article-title":"New challenges for the diagnosis of feline immunodeficiency virus infection","volume":"37","author":"Crawford","year":"2007","journal-title":"Vet. Clin. N. Am. Small Anim. Pract."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.2460\/javma.1991.199.10.1413","article-title":"Feline leukemia virus vaccine development","volume":"199","author":"Sebring","year":"1991","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.2460\/javma.1991.199.10.1446","article-title":"Vaccination of cats experimentally infected with feline immunodeficiency virus, using a recombinant feline leukemia virus vaccine","volume":"199","author":"Lehmann","year":"1991","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.2460\/javma.1991.199.10.1456","article-title":"Comparison of the efficacy of three commercial feline leukemia virus vaccines in a natural challenge exposure","volume":"199","author":"Legendre","year":"1991","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1177\/1098612X20941785","article-title":"Feline leukaemia virus infection: A practical approach to diagnosis","volume":"22","author":"Hartmann","year":"2020","journal-title":"J. Feline Med. Surg."},{"key":"ref_45","first-page":"3642","article-title":"Humoral immune reactivity to feline leukemia virus and associated antigens in cats naturally infected with feline leukemia virus","volume":"40","author":"Lutz","year":"1980","journal-title":"Cancer Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/1098612X19895940","article-title":"2020 AAFP Feline Retrovirus Testing and Management Guidelines","volume":"22","author":"Little","year":"2020","journal-title":"J. Feline Med. Surg."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1016\/j.vaccine.2005.10.030","article-title":"Antibody induction after combined application of an adjuvanted recombinant FeLV vaccine and a multivalent modified live virus vaccine with a chlamydial component","volume":"24","author":"Brunner","year":"2006","journal-title":"Vaccine"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0264-410X(89)90157-6","article-title":"Effect of anatomic injection site, age and smoking on the immune response to hepatitis B vaccination","volume":"7","author":"Shaw","year":"1989","journal-title":"Vaccine"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.rvsc.2018.11.005","article-title":"Vaccination at different anatomic sites induces different levels of the immune responses","volume":"122","author":"Jin","year":"2019","journal-title":"Res. Vet. Sci."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.rvsc.2020.03.018","article-title":"Higher immune response induced by vaccination in Houhai acupoint relates to the lymphatic drainage of the injection site","volume":"130","author":"Jin","year":"2020","journal-title":"Res. Vet. Sci."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1177\/1098612X15588451","article-title":"Feline injection site sarcoma: ABCD guidelines on prevention and management","volume":"17","author":"Hartmann","year":"2015","journal-title":"J. Feline Med. Surg."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1177\/1098612X13505579","article-title":"Tail vaccination in cats: A pilot study","volume":"16","author":"Hendricks","year":"2014","journal-title":"J. Feline Med. Surg."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"726","DOI":"10.2460\/javma.228.5.726","article-title":"Protection from challenge following administration of a canarypox virus\u2013vectored recombinant feline leukemia virus vaccine in cats previously vaccinated with a killed virus vaccine","volume":"228","author":"Grosenbaugh","year":"2006","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_54","first-page":"258","article-title":"Comparison of the safety and efficacy of a recombinant feline leukemia virus (FeLV) vaccine delivered transdermally and an inactivated FeLV vaccine delivered subcutaneously","volume":"5","author":"Grosenbaugh","year":"2004","journal-title":"Vet. Ther."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1751-0813.1993.tb06101.x","article-title":"The effects of antigenic competition on the efficacy of multivalent footrot vaccines","volume":"70","author":"Schwartzkoff","year":"1993","journal-title":"Aust. Vet. J."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1542\/peds.109.1.124","article-title":"Addressing parents\u2019 concerns: Do multiple vaccines overwhelm or weaken the infant\u2019s immune system?","volume":"109","author":"Offit","year":"2002","journal-title":"Pediatrics"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.trivac.2013.12.002","article-title":"Co-administration of an adjuvanted FeLV vaccine together with a multivalent feline vaccine to cats is protective against virulent challenge with feline leukaemia virus, calicivirus, herpes virus and panleukopenia virus","volume":"3","author":"Wilson","year":"2014","journal-title":"Trials Vaccinol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1136\/vr.153.5.141","article-title":"Efficacy of a canarypox virus-vectored vaccine against feline leukaemia","volume":"153","author":"Poulet","year":"2003","journal-title":"Vet. Rec."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"108865","DOI":"10.1016\/j.vetmic.2020.108865","article-title":"Lack of protection against feline immunodeficiency virus infection among domestic cats in New Zealand vaccinated with the Fel-O-Vax\u00ae FIV vaccine","volume":"250","author":"Stickney","year":"2020","journal-title":"Vet. Microbiol."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/13\/2\/240\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:19:44Z","timestamp":1760159984000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/13\/2\/240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,3]]},"references-count":59,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,2]]}},"alternative-id":["v13020240"],"URL":"https:\/\/doi.org\/10.3390\/v13020240","relation":{},"ISSN":["1999-4915"],"issn-type":[{"type":"electronic","value":"1999-4915"}],"subject":[],"published":{"date-parts":[[2021,2,3]]}}}